awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37459705-6C2B718A-74DD-4642-BBFA-40241F4A7C62
Q37459705-6C2B718A-74DD-4642-BBFA-40241F4A7C62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37459705-6C2B718A-74DD-4642-BBFA-40241F4A7C62
Bevacizumab for recurrent ependymoma.
P2860
Q37459705-6C2B718A-74DD-4642-BBFA-40241F4A7C62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37459705-6C2B718A-74DD-4642-BBFA-40241F4A7C62
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
785f222500bacd014726714910481134a2fd7573
P2860
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma